Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

Active, not recruitingOBSERVATIONAL
Enrollment

675

Participants

Timeline

Start Date

April 1, 2019

Primary Completion Date

March 31, 2026

Study Completion Date

June 30, 2026

Conditions
Patent Ductus ArteriosusPreterm InfantBronchopulmonary DysplasiaNeurodevelopmental Abnormality
Trial Locations (4)

43205

Nationwide Children's Hospital Main Campus Neonatal Intensive Care Unit, Columbus

43210

Nationwide Children's Neonatal Intensive Care Unit at The Ohio State University Wexner Medical Center, Columbus

43214

Nationwide Children's Neonatal Intensive Care Unit at OhioHealth Riverside Methodist Hospital, Columbus

43215

Nationwide Children's Hospital Neonatal Intensive Care Unit at OhioHealth Grant Medical Center, Columbus

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Ohio State University

OTHER

collaborator

OhioHealth

OTHER

collaborator

Mount Carmel Health System

OTHER

lead

Nationwide Children's Hospital

OTHER